| 000 | 01089 a2200313 4500 | ||
|---|---|---|---|
| 005 | 20250517033658.0 | ||
| 264 | 0 | _c20150723 | |
| 008 | 201507s 0 0 eng d | ||
| 022 | _a1549-4713 | ||
| 024 | 7 |
_a10.1016/j.ophtha.2014.10.024 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aBrown, David M | |
| 245 | 0 | 0 |
_aAuthor reply: To PMID 25012934. _h[electronic resource] |
| 260 |
_bOphthalmology _cJun 2015 |
||
| 300 |
_ae38-9 p. _bdigital |
||
| 500 | _aPublication Type: Letter; Comment | ||
| 650 | 0 | 4 |
_aAngiogenesis Inhibitors _xtherapeutic use |
| 650 | 0 | 4 |
_aDiabetic Retinopathy _xdrug therapy |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aLaser Coagulation |
| 650 | 0 | 4 |
_aMacular Edema _xdrug therapy |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aReceptors, Vascular Endothelial Growth Factor _xtherapeutic use |
| 650 | 0 | 4 |
_aRecombinant Fusion Proteins _xtherapeutic use |
| 700 | 1 | _aKorobelnik, Jean-Francois | |
| 773 | 0 |
_tOphthalmology _gvol. 122 _gno. 6 _gp. e38-9 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.ophtha.2014.10.024 _zAvailable from publisher's website |
| 999 |
_c24932670 _d24932670 |
||